MedPath

Head-dOwn Position for ischEmic Stroke With Middle Cerebral Artery (HOPES)

Not Applicable
Terminated
Conditions
Ischemic Stroke
Interventions
Other: head-down position treatment
Other: Conventional Rehabilitation
Registration Number
NCT03629652
Lead Sponsor
General Hospital of Shenyang Military Region
Brief Summary

The study is designed to explore the efficacy and safety of head-down position in patients with acute ischemic stroke。

Detailed Description

Currently, the guideline recommended re-perfusion such as intravenous thrombolysis and mechanical thrombectomy as the most effective treatment for acute ischemic stroke. However, the two methods are restricted by a strict time window, which greatly limits the number of the patients receiving treatment. The abundant studies have suggested that good collateral circulation can provide compensatory blood supply to save the ischemic penumbra and reduces the infarct volume, which improves the prognosis. How to improve collateral circulation in an efficient and safe way is a clinical challenge. Our recent experiment results of the animal and clinical experiments show that head-down position can significantly increase cerebral perfusion and improve neurological function. Clinically, head-down position is simple and easy to operate, and theoretically may increases brain perfusion and improve collateral circulation. A pilot randomized clinical trial is designed to investigate the effect of head-down position combined with routine rehabilitation in patients with ischemic stroke.

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
12
Inclusion Criteria
  1. age ≥18 years
  2. acute ischemic stroke within 10 - 30 days of onset
  3. neurological deficit: 6≤NIHSS≤16
  4. Large artery atherosclerosis stroke based on TOAST criteria
  5. The responsibility vessels were the middle cerebral artery or internal carotid artery, and the degree of stenosis was more than 50%.
  6. first stroke onset or past stroke without obvious neurological deficit (mRS≤1)
  7. fully understand and cooperate with the doctor's instructions.
  8. the availability of informed consent;
Exclusion Criteria
  1. Hemorrhagic stroke or mixed stroke
  2. Combining with severe organ dysfunction
  3. Past hemorrhagic stroke
  4. A history of stroke with severe sequelae
  5. Planning revascularization in 3 months
  6. Ischemic stroke due to surgical intervention
  7. participating in other clinical trials within 3 months
  8. Pregnant or lactating women
  9. any inappropriate patients assessed by the researcher

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Head down positionhead-down position treatmenthead-down position treatment combined with conventional rehabilitation.
Conventional RehabilitationConventional RehabilitationConventional rehabilitation treatment
Head down positionConventional Rehabilitationhead-down position treatment combined with conventional rehabilitation.
Primary Outcome Measures
NameTimeMethod
proportion of patients with modified Rankin Score 0 to 290 days
Secondary Outcome Measures
NameTimeMethod
proportion of patients with modified Rankin Score 0 to 190 days
occurrence of stroke90 days

stroke or TIA

The percentage of reduction in MoCA90 days

MoCA, Montreal Congnitive Assessment

Incidence of major vascular events90 days

ischemic stroke, hemorrhagic stroke, TIA, myocardial infarction, vascular death

the biggest tolerance time of head-down90 days
The percentage of reduction in Fugl-Meyer score90 days
The percentage of reduction in MMSE90 days

MMSE,Mini-mental State Examination

Trial Locations

Locations (1)

General Hospital of ShenYang Military Region

🇨🇳

ShenYang, Liaoning, China

© Copyright 2025. All Rights Reserved by MedPath